William G. Monroe IV
Known title: Chief Financial OfficerCIK: 0001979682
Associated companies
Transaction History
| CHCT | ▲ Buy | Grant | 27,573 | $426K | 8/18/2026 | View on chart |
| CHCT | ▲ Buy | Grant | 10,163 | $0 | 7/30/2026 | View on chart |
| CHCT | ▼ Sell | Tax Withholding | 1,630 | $29K | 6/30/2026 | View on chart |
| CHCT | ▲ Buy | Grant | 29,605 | $494K | 1/15/2026 | View on chart |
| CHCT | ▲ Buy | Grant | 29,009 | $460K | 8/7/2025 | View on chart |
| CHCT | ▲ Buy | Grant | 11,433 | $0 | 7/24/2025 | View on chart |
| CHCT | ▼ Sell | Tax Withholding | 650 | $11K | 6/30/2025 | View on chart |
| CHCT | ▲ Buy | Grant | 7,000 | $0 | 6/2/2025 | View on chart |
| CHCT | ▲ Buy | Grant | 25,981 | $494K | 1/15/2025 | View on chart |
| CHCT | ▲ Buy | Grant | 43,502 | $989K | 8/8/2024 | View on chart |
| CHCT | ▼ Sell | Tax Withholding | 641 | $15K | 7/1/2024 | View on chart |
| CHCT | ▲ Buy | Grant | 7,000 | $0 | 6/3/2024 | View on chart |
| CHCT | ▲ Buy | Grant | 18,987 | $494K | 1/12/2024 | View on chart |
| CHCT | ▲ Buy | Grant | 8,062 | $0 | 1/2/2024 | View on chart |
| CHCT | ▲ Buy | Grant | 2,699 | $96K | 8/10/2023 | View on chart |
| CHCT | ▲ Buy | Grant | 14,497 | $0 | 7/27/2023 | View on chart |
| CHCT | ▲ Buy | Grant | 16,322 | $560K | 6/15/2023 | View on chart |
| CHCT | ▲ Buy | Grant | 7,000 | $0 | 6/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Evercore ISI Lowers CHCT Price Target to $17
Evercore ISI Group has maintained its In-Line rating on Community Healthcare Trust but lowered its price target to $17. This move places the firm's estimate at the lower end of the current analyst range, which spans from $17.00 to $18.00. The adjustment reflects a modestly more conservative outlook for the company's near-term performance relative to previous expectations.
Evercore ISI Lowers CHCT Price Target to $17. Evercore ISI Group has maintained its In-Line rating on Community Healthcare Trust but lowered its price target to $17. This move places the firm's estimate at the lower end of the current analyst range, which spans from $17.00 to $18.00. The adjustment reflects a modestly more conservative outlook for the company's near-term performance relative to previous expectations.